Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10010162HBVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS10043039HBVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS30079405HIVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS30086094HIVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS20006710HPVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS20052673HPVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS20026978HPVENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS44017912HTLV-1ENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS44029752HTLV-1ENSG00000087245.13protein_codingMMP2NoNo4313P08253
TVIS44029763HTLV-1ENSG00000087245.13protein_codingMMP2NoNo4313P08253
TCGA Plot Options
Drug Information
GeneMMP2
DrugBank IDDB04866
Drug NameHalofuginone
Target IDBE0000642
UniProt IDP08253
Regulation Type
PubMed IDs11099465
CitationsElkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I, Dou HL, Pines M, Vlodavsky I: Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J. 2000 Dec;14(15):2477-85.
GroupsInvestigational; Vet_approved
Direct ClassificationQuinazolines
SMILES[H][C@]1(O)CCCN[C@]1([H])CC(=O)CN1C=NC2=C(C=C(Cl)C(Br)=C2)C1=O
Pathways
PharmGKB
ChEMBLCHEMBL1199540